| Product Name |
Fulvestrant Inhouse Impurity 9 / (7S,8R,9S,13S,14S,17S)-3-hydroxy-13-methyl-7-(9-((methylsulfonyl)oxy)nonyl)-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthren-17-yl acetate
|
| Product Category |
Impurities, Intermediates |
| Sub-Category |
Metabolites, Pharmaceutical Standards, Fine Chemicals |
| CAS No |
1621885-80-0 |
| Catalog Number |
GS.47.FUL.39 |
| Chemical Name/Synonyms |
(7S,8R,9S,13S,14S,17S)-3-hydroxy-13-methyl-7-(9-((methylsulfonyl)oxy)nonyl)-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthren-17-yl acetate |
| Molecular Weight |
534.76 |
| Molecular Formula |
C30H46O6S |
| Purity |
NLT 95 % |
| Applications |
It is an impurtity of Fulvestrant which is used to treat hormone receptor-positive metastatic breast cancer in postmenopausal women. |
| Inventory Status |
customized
|
